Format

Send to

Choose Destination
Pediatr Emerg Care. 2003 Dec;19(6):385-92.

The safe and effective use of propofol sedation in children undergoing diagnostic and therapeutic procedures: experience in a pediatric ICU and a review of the literature.

Author information

1
Department of Pediatrics, Naval Medical Center, San Diego, CA, USA. dewheeler@mcg.edu

Abstract

OBJECTIVES:

To describe our experience using propofol sedation to facilitate elective diagnostic and therapeutic procedures, and to document the safety profile of propofol in this setting.

DESIGN:

Retrospective consecutive case series and review of the literature.

SETTING:

Pediatric intensive care unit of a United States Navy tertiary care medical center.

PATIENTS:

Children receiving propofol for procedural sedation over an 18-month period.

OUTCOME MEASURES:

Descriptive features of sedation including adverse events.

RESULTS:

During the study period, 91 children received propofol to facilitate the performance of 110 medical procedures. The mean induction dose was 2.41 mg/kg, the mean infusion rate was 179.3 microg/kg/min, and the mean total dose of propofol administered was 4.23 mg/kg. In all cases, sedation was successfully achieved. The average length of stay in the PICU was 108.4 minutes. Three children (3.3%) had transient episodes of oxygen desaturation that improved with repositioning of the airway. No child required placement of an endotracheal tube. Three (3.3%) children experienced hypotension requiring a decrease in the infusion rate of propofol and a 10-mL/kg bolus infusion of normal saline. No cardiac arrhythmias or adverse neurologic effects secondary to propofol infusion were identified.

CONCLUSIONS:

Pediatric intensivists can safely and effectively administer propofol to facilitate the performance of diagnostic and therapeutic procedures outside the operating room setting.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center